From: Nano-level assay of attention-deficit/hyperactivity disorder medicament, atomoxetine by molecular-size-based resonance rayleigh scattering strategy. Employment in content uniformity, dosage form, and plasma analysis
Conc. level (ng/mL)
Recovery*± SD
% Error
200
99.20 ± 1.23
0.80
500
98.26 ± 0.65
1.74
900
98.88 ± 1.08
1.12
1000
101.38 ± 1.67
1.38